TABLE 2.
the expression and role of miR-192-5p in different human cancers. NA, not available.
| Human system | Tumor type | MiR-192-5p | Role | References |
|---|---|---|---|---|
| Respiratory | NPC | Up | NA | Zou et al. (2020) |
| NSCLC | Down | Tumor suppressor | Ye et al. (2015) | |
| LUAD | Up | NA | Xue et al. (2020) | |
| Digestive | HCC | Controversy | NA | Yan-Chun et al. (2017), Gu et al. (2019), and Zhu et al. (2019) |
| Esophageal cancer | Up | Oncogene | Bansal et al. (2014), Huang et al. (2017) | |
| Colorectal cancer | Controversy | NA | Della Vittoria Scarpati et al. (2014), Zhao et al. (2020a) | |
| Gastric cancer | Down | Tumor suppressor | Xie et al. (2019), Tavakolian et al. (2020) | |
| Urinary | BC | Down | Tumor suppressor | Ji et al. (2018) |
| Reproductive | Breast cancer | Controversy | NA | Kim et al. (2016), Chen et al. (2018), Fang et al. (2018), and Zhang et al. (2019) |
| Cervical cancer | Up | NA | Kori and Yalcin Arga (2018) | |
| Ovarian cancer | Up | Oncogene | Liu W et al. (2017) | |
| Prostate cancer | Up | Oncogene | Chen ZJ et al. (2019) | |
| Endocrine | Pancreatic cancer | Up | NA | Zhou X et al. (2018), Zou X et al., 2019 |
| Motor | Osteosarcoma | Down | Tumor suppressor | Zhou S et al. (2018) |